SEC Tracker
Get the app

biote BTMD

biote reports $43.33 million revenue for Q3 2026

biote (BTMD) filed a 10-Q with the SEC on Nov 9, 2026, 5:08 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Major
  1. Revenue: $43.33 million for the three months ended Sep 30, 2026
  2. Net income: $407,000 for the three months ended Sep 30, 2026
  3. Cash and equivalents: $8.85 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when biote files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

1 new risk factor · 1 new legal mention

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Revenue$43.33M$44.23M−2%
Operating income and margin$2.49M · 5.7%−$3.51M · -7.9%+171%, margin +13.6 pts
Net income$407K−$6.56M+106%
Operating cash flow$3.69M−$1.18M+413%
Cash$8.85M$11.17M−21%
New risk factors (1)
  • Our credit agreement with Truist Bank contains affirmative, negative and financial covenants that may limit our flexibility in operating our businesses. +3 more paragraphs
New legal mentions (1)
  • The Company paid $0.8 million of the amounts due under these settlement agreements during the three months ended September 30, 2026. +1 more paragraph

Data on this page was fetched . The filing on SEC.gov is the record.